Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason E Comer

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Biorxiv : the Preprint Server for Biology|January 5, 2021
Cell-type apoptosis in lung during SARS-CoV-2 infectionYakun Liu, Tania M Garron, Qing Chang, et al.
The Journal of Infectious Diseases|June 22, 2023
Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant MakonaAbhishek N Prasad, Krystle N Agans, Joan B Geisbert, et al.
Infection and Immunity|January 24, 2006
Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthraxJohnny W Peterson, Jason E Comer, David M Noffsinger, et al.
Antiviral Research|November 15, 2022
The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N<sup>4</sup>-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infectionGregory R Bluemling, Shuli Mao, Michael G Natchus, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
A safe insect-based Chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaquesAwadalkareem Adam, Courtney Woolsey, Hannah Lu, et al.
NPJ Vaccines|December 20, 2024
A safe insect-based chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaquesAwadalkareem Adam, Courtney Woolsey, Hannah Lu, et al.
Vaccines|June 2, 2021
A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus MacaquesPaul E Harris, Trevor Brasel, Christopher Massey, et al.
Pathogens (Basel, Switzerland)|April 30, 2021
Cell-Type Apoptosis in Lung during SARS-CoV-2 InfectionYakun Liu, Tania M Garron, Qing Chang, et al.
NPJ Vaccines|January 6, 2026
Passive transfer of human sera from chikungunya virus virus-like particle vaccine (Vimkunya) recipients fully protects non-human primates from viremiaChristopher S Morello, Ravi Anantha, Jason E Comer, et al.
Vaccine|February 23, 2020
Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challengeIrina Tretyakova, Kenneth S Plante, Shannan L Rossi, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|January 5, 2021
Cell-type apoptosis in lung during SARS-CoV-2 infectionYakun Liu, Tania M Garron, Qing Chang, et al.
The Journal of Infectious Diseases|June 22, 2023
Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant MakonaAbhishek N Prasad, Krystle N Agans, Joan B Geisbert, et al.
Infection and Immunity|January 24, 2006
Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthraxJohnny W Peterson, Jason E Comer, David M Noffsinger, et al.
Antiviral Research|November 15, 2022
The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N<sup>4</sup>-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infectionGregory R Bluemling, Shuli Mao, Michael G Natchus, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
A safe insect-based Chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaquesAwadalkareem Adam, Courtney Woolsey, Hannah Lu, et al.
NPJ Vaccines|December 20, 2024
A safe insect-based chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaquesAwadalkareem Adam, Courtney Woolsey, Hannah Lu, et al.
Vaccines|June 2, 2021
A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus MacaquesPaul E Harris, Trevor Brasel, Christopher Massey, et al.
Pathogens (Basel, Switzerland)|April 30, 2021
Cell-Type Apoptosis in Lung during SARS-CoV-2 InfectionYakun Liu, Tania M Garron, Qing Chang, et al.
NPJ Vaccines|January 6, 2026
Passive transfer of human sera from chikungunya virus virus-like particle vaccine (Vimkunya) recipients fully protects non-human primates from viremiaChristopher S Morello, Ravi Anantha, Jason E Comer, et al.
Vaccine|February 23, 2020
Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challengeIrina Tretyakova, Kenneth S Plante, Shannan L Rossi, et al.
Pageof 5